Eurofins Scientific to acquire Advinus Therapeutics

On July 26th 2017, Eurofins Scientific (EUFI.PA), a global leader in bio-pharmaceutical product testing services, announced that it had signed an exclusive agreement with Tata Group to acquire Advinus Therapeutics (“Advinus”), a leading preclinical and clinical phase contract research company for Safety Assessment, DMPK, CMC services, and Analytical R&D Services. 

The transaction is expected to close in the next few weeks, subject to the fulfilment of customary closing conditions. With over 25 years of GLP compliance and certification, Advinus serves diverse industries such as Biotech, Pharmaceuticals, Biologics, Agrochemicals, Nutraceuticals and Cosmetics.  Please click here for the full press release.

Eurofins Agroscience Services, a division of Eurofins Scientific, is pleased to share this news as the acquisition is also a major step forward in the development of the Agroscience portfolio in that region.

Located in Bangalore, India, the company operates a state-of-the art 20,000 m2 facility on a large campus with ample space for expansion. Advinus has an established ecotoxicology and chemistry laboratory synergizing with existing activities in Asia. Together with Advinus, Eurofins Agroscience Services are able accelerate delivery of a full portfolio of services in the Asian region.

Eurofins Scientific looks forward to having an enhanced service offering once the transaction is completed.

Please direct any questions to Friedrich Knecht: FriedrichKnecht@eurofins.com, EAS Group COO.